Psychiatric Manifestations of Homocystinuria Due to Cystathionine Beta-synthase Deficiency: Prevalence, Natural History, and Relationship to Neurologic Impairment and Vitamin B6-responsiveness
Overview
Authors
Affiliations
Homocystinuria commonly affects the central nervous system (CNS), primarily as mental retardation, seizures, and stroke. Case reports have long suggested a predisposition to schizophrenia, but no careful study of predisposition to psychiatric illness has been performed. Accordingly, we evaluated 63 persons with homocystinuria due to cystathionine beta-synthase deficiency for psychiatric disturbance, intelligence, evidence of other CNS problems, and responsiveness to vitamin B6. The overall rate of clinically significant psychiatric disorders was 51%, predominated by four diagnostic categories: episodic depression (10%), chronic disorders of behavior (17%), chronic obsessive-compulsive disorder (5%), and personality disorders (19%). The average IQ was 80 +/- 27 (1 SD); and an IQ of less than or equal to 79 was two-thirds more common among vitamin B6-nonresponsive patients compared to vitamin B6-responsive patients. Aggressive behavior and other disorders of conduct were particularly common among patients with mental retardation and among vitamin B6-nonresponsive patients.
Homocysteine Thiolactone Detoxifying Enzymes and Alzheimer's Disease.
Jakubowski H Int J Mol Sci. 2024; 25(15).
PMID: 39125665 PMC: 11312131. DOI: 10.3390/ijms25158095.
Psychiatric Manifestations in Children and Adolescents with Inherited Metabolic Diseases.
Baglioni V, Bozza F, Lentini G, Beatrice A, Cameli N, Cinnante E J Clin Med. 2024; 13(8).
PMID: 38673463 PMC: 11051134. DOI: 10.3390/jcm13082190.
Hyperhomocysteinemia in Adult Patients: A Treatable Metabolic Condition.
Gonzalez-Lamuno D, Arrieta-Blanco F, Fuentes E, Forga-Visa M, Morales-Conejo M, Pena-Quintana L Nutrients. 2024; 16(1).
PMID: 38201964 PMC: 10780827. DOI: 10.3390/nu16010135.
Fehsel K Biomedicines. 2023; 11(9).
PMID: 37760862 PMC: 10526115. DOI: 10.3390/biomedicines11092421.
Zhilyaeva T, Piatoikina A, Bavrina A, Kostina O, Zhukova E, Shcherbatyuk T Schizophr Res Treatment. 2021; 2021:7721760.
PMID: 34707909 PMC: 8545596. DOI: 10.1155/2021/7721760.